Pluristyx Announces Strategic Alliance with panCELLa and Implant Therapeutics of Offer ‘Off-the-Shelf’ Induced Pluripotent Stem Cells

Pluristyx, Inc., panCELLa, and Implant Therapeutics announced they have entered into a manufacturing and distribution strategic alliance that offers cell therapy companies streamlined access to the next generation of safe, universal, cost-effective, “off-the-shelf” iPSCs.